SARS-CoV-2 omicron infection
Conditions
Interventions
Control group:no
SARS-CoV-2 omicron Group:no
Sponsors
Army Medical Center of PLA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 Voluntarily sign the "informed consent form" to participate in this study 2. Relevant clinical data meeting the trial needs can be obtained from the subjects, including but not limited to patient epidemiological data, demographic data, clinical symptoms and signs, imaging data, laboratory examination data, histopathology, treatment methods, other follow-up information, etc 3. A Clinical manifestations related to COVID-19 infection; B COVID-19 nucleic acid test was positive; C COVID-19 antigen was positive; D COVID-19 was positive in isolation and culture; E The level of COVID-19 specific IgG antibody in the recovery phase is four times or more higher than that in the acute phase. Conform to one or more of a, b, c and d
Exclusion criteria
Exclusion criteria: 1 Patients who refuse to sign the informed consent form 2. Take conservative treatment after admission 3. Participation in other studies affects the observation of this study 4 Patients with high-risk diseases or other special circumstances that are not suitable for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| preoperative COVID-19 symptoms;Preoperative COVID-19 test;Time from symptom onset to surgery;Time from positive COVID-19 test to surgery;D-dimer;C-reaction protein;ASA class;surgical difficulty category;surgery duration;pathology;type of operation;complication;Clavien Dindo classification;comprehensive complication index; | — |
Secondary
| Measure | Time frame |
|---|---|
| age;gender;Body Mass Index;Comorbidities;smoking status;complete blood count;anesthesia duration;blood loss volume; | — |
Countries
China
Contacts
Public ContactLiu Peng
Daping Hospital of Army Medical University
Outcome results
None listed